Skip to main content
Clinical Trials/NCT04235595
NCT04235595
Completed
Not Applicable

Comparison of the Effects of High-frequency TENS and Connective Tissue Manipulation on the Primary Dysmenorrhea

Izmir Bakircay University0 sites40 target enrollmentSeptember 1, 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Primary Dysmenorrhea
Sponsor
Izmir Bakircay University
Enrollment
40
Primary Endpoint
Assessment of Pain Severity
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

this study was to compare the early and short-term effects of high-frequency transcutaneous electrical nerve stimulation (TENS) versus connective tissue manipulation (CTM) in participants with primary dysmenorrhea. Half of the participants received CTM, while the other half received TENS.

Detailed Description

CTM and TENS each relieve dysmenorrhea pain, but they do so by different. The electrotherapy modality that is most commonly used in the treatment of dysmenorrhea is TENS. It has been reported in studies that high-frequency TENS is more effective in reducing pain than either low-frequency TENS or placebo TENS. A scan of the literature reveals that although there are differing opinions and applications related to the number and duration of CTM, it has been shown that women with primary dysmenorrhea experience reduced pain after CTM,

Registry
clinicaltrials.gov
Start Date
September 1, 2015
End Date
August 30, 2016
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Sponsor
Izmir Bakircay University
Responsible Party
Principal Investigator
Principal Investigator

Nilay Yürekdeler Şahin

Assistant Professor

Izmir Bakircay University

Eligibility Criteria

Inclusion Criteria

  • being between the ages of 18-30
  • having a diagnosis of primary dysmenorrhea

Exclusion Criteria

  • having used an oral contraceptive in the last 3 months,
  • having an active sexual life,
  • pregnancy,
  • having gone through childbirth,
  • having a neurological deficit,
  • any kind of systemic condition,
  • a diagnosed gynecological condition (pelvic inflammatory diseases, endometriosis, uterus cancers, ovarian cysts, etc.),
  • taking psychotherapeutic drugs.

Outcomes

Primary Outcomes

Assessment of Pain Severity

Time Frame: Change from Pain severity at 3 months

To determine the localization of pain, the participants were asked to point out and mark the place(s) they felt the most pain on a body diagram. The severity of the pain of dysmenorrhea was assessed on a 10-cm Visual Analog Scale (VAS).

Secondary Outcomes

  • Assessment of Depressive Symptoms(Change from Beck Depression Inventory score at 3 months)
  • Assessment of Anxiety(Change from Beck Anxiety Inventory score at 3 months)
  • Assessment of Sleep Disorders and Fatigue(Change from Sleep Disorders and Fatigue severity at 3 months)
  • Assessment of General Health Status(Change from General Health Questionnaire score at 3 months)

Similar Trials